Trial Profile
Nicotinic Receptors and Schizophrenia.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Feb 2016
Price :
$35
*
At a glance
- Drugs GTS 21 (Primary)
- Indications Schizophrenia
- Focus Pharmacokinetics
- 01 Jan 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 Nov 2011 Planned End Date changed from 1 Jan 2014 to 1 Jan 2015 as reported by ClinicalTrials.gov.
- 19 May 2010 Planned end date changed from 1 Sep 2011 to 1 Jan 2014 as reported by ClinicalTrials.gov.